# Wonder Sciences

> Wonder Sciences is a Los Angeles-based mental health and research company reengineering psychiatric care through psychedelic medicine, clinical research, and AI. Best known for its consumer brand Wondermed - an at-home, low-dose ketamine-assisted telehealth protocol for anxiety and depression - the company is building an AI-native clinical operating system that fuses medication, therapy, and behavioral data into actionable insights. Founded by Ryan Magnussen in 2022, it raised roughly $4.6M-$5.6M in seed funding from investors including Aubrey Marcus and James Foster.

- **Founded:** 2022
- **Headquarters:** Los Angeles, California, United States
- **Founders:** Ryan Magnussen (Founder & CEO)
- **Team size:** ~17 employees
- **Products:** Wondermed, Wondermed_AI, WonderMate, Wonder Research, Wonder IMPACT
- **Notable:** Launched Wondermed in June 2022, bringing at-home ketamine-assisted therapy to consumers across 11 states., Raised roughly $4.6M-$5.6M in seed funding from notable health and wellness investors., Backed by James Foster, CEO of Charles River Laboratories, and Aubrey Marcus, founder of Onnit.

## Products & services

- **Wondermed** — An at-home, low-dose ketamine-assisted telehealth protocol for anxiety and depression. Includes a clinician-led pre-screening, ketamine lozenges for self-led sessions, musicologist-produced soundscapes, and a personalized preparation and integration dashboard. Launched at roughly $399/month.
- **Wondermed_AI** — An AI-native clinical operating system for precision mental healthcare that integrates medication, therapy, and behavioral data to generate clinically actionable insights (positioned as FDA Software as a Medical Device).
- **WonderMate** — An AI therapist and clinical co-pilot built on longitudinal cognitive modeling and human-led safety protocols.
- **Wonder Research** — FDA clinical studies, psychedelic science research, and development of novel therapeutic protocols.
- **Wonder IMPACT** — Business development arm focused on mission-aligned partnerships that advance mental healthcare.
- **Wonder Humans** — Recruitment and team-building function for the company.

## Achievements

- Launched Wondermed in June 2022, bringing at-home ketamine-assisted therapy to consumers across 11 states.
- Raised roughly $4.6M-$5.6M in seed funding from notable health and wellness investors.
- Backed by James Foster, CEO of Charles River Laboratories, and Aubrey Marcus, founder of Onnit.
- Building toward an FDA Software as a Medical Device AI clinical platform.

## Latest updates

- **2022-06** — Wonder Sciences launches Wondermed, an at-home ketamine-assisted self-healing treatment for anxiety and mental health disorders.
- **2022-06** — Closes seed funding round of roughly $4.6M-$5.6M from investors including Aubrey Marcus and James Foster.
- **2026-05** — Company positions itself around an AI-native clinical operating system (Wondermed_AI / WonderMate) for precision mental healthcare.

## Links

- Website: https://wondersciences.com
- LinkedIn: https://www.linkedin.com/company/wondersciences
- Instagram: https://www.instagram.com/wondermedhealth/

---

Profile page: https://yespress.io/wonder-sciences
Published by YesPress — https://yespress.io
Last updated: 2026-07-02